Canada· CA-DIN-02329336

ULTRATAG RBC

A 99mtc-technetium-zinn markierte zellen product containing technetium tc 99m red blood cells, registered in Canada by CURIUM CANADA INC. The same ATC class is registered in 8 of our 19 countries.

ATC V09GA06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedULTRATAG RBCATCV09GA06REGISTER NO.CA-DIN-02329336PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

99mtc-technetium-zinn markierte zellen is registered in 8 of 19 countries.

Countries holding a registration under ATC V09GA06 (99mtc-technetium-zinn markierte zellen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 4 of them publish a price we can compare per daily dose

99mtc-technetium-zinn markierte zellen · ATC V09GA06

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TECHNETIUM TC 99M RED BLOOD CELLS
Manufacturer
CURIUM CANADA INC
Country
Canada (CA)
ATC code
V09GA06
ATC class
99mTc-Technetium-Zinn markierte Zellen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6c062d0-0dee-4851-915f-030b644395f2
GET /v1/drugs/c6c062d0-0dee-4851-915f-030b644395f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02329336",
  "form": "SOLUTION",
  "class": "Radiopharmaceutical",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V09GA06",
  "schedule": [
    "Schedule C"
  ],
  "drug_code": "81508",
  "strengths": [
    "20 MCI"
  ],
  "ahfs_class": null,
  "substances": [
    "TECHNETIUM TC 99M RED BLOOD CELLS"
  ],
  "product_categorization": null
}

See everything about 99mtc-technetium-zinn markierte zellen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.